
Photo: depositphotos.com
Jul 11, 2025, 18:45
Ed Esplin: Is There Any Patient Who Should Not Have Germline Genetic Testing to Aid Treatment Decision Making?
Ed Esplin, Clinical Geneticist at Invitae, shared on X:
“2026 NCCN Genetic guidelines page CRIT-1
“GENERAL TESTING CRITERIA
Germline testing is clinically indicated in the following scenarios: To aid in systemic therapy and surgical decision-making”
Is there any patient with breast, ovarian, pancreas, prostate, colorectal, gastric, endometrial cancer who should not have germline genetic testing to aid in systemic therapy and surgical decision making?”
Title: Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis
Authors: Vivek Subbiah, Razelle Kurzrock
Read The Full Article at JCO ASCO.
More posts featuring Germline Genetic Testing.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 11, 2025, 18:04
Jul 11, 2025, 17:27
Jul 11, 2025, 17:17
Jul 11, 2025, 16:54